Cite
APA Citation
Pleyer, C., Tian, X., Rampertaap, S., Mu, R., Soto, S., Superata, J., Gaglione, E., Sun, C., Lotter, J., Stetler‐Stevenson, M., Yuan, C. M., Maric, I., Pittaluga, S., Rosenzweig, S., Fleisher, T., Wiestner, A., & Ahn, I. E. (n.d.). a phase II study of ibrutinib and short‐course fludarabine in previously untreated patients with chronic lymphocytic leukemia. American journal of hematology, 95(11), E310–E313. http://access.bl.uk/ark:/81055/vdc_100114048269.0x000030